Share this post:

Following on from the launch of the Antimicrobial Resistance Benchmark, this article covers the sharp decrease in the number of new antibiotics being developed and how companies need to do much more to tackle the rise of superbugs.

“These companies produce the most antibiotics and some have only recently started tackling antibiotic resistance.”

Read full article